A brief explanation of who we are and what we do @neo7bioscience Reach out to us if you have cancer or a vaccine related injury.

Thank you, @eitchan for your excellent coverage of the Spike Prion! 💪@P_McCulloughMD @NicHulscher @McCulloughFund @neo7bioscience

The Best Business and Health Care Decision for America Pull mRNA products from public use. Now. President Trump and Secretary Kennedy must not waver with Pfizer, Moderna, Merck, or anyone else selling mRNA gene products. The platform is the problem. Hold the line. Substack Article Link: johncatanzaro.substack.com/p… @P_McCulloughMD @NicHulscher @MaryBowdenMD @HHSGov @SecKennedy @POTUS45 @FDA @CDCgov @AmerHlthFreedom

💯💪

💪SHUT DOWN = RIGHT DIRECTION ❌SUPPORT = WRONG DIRECTION! "The Department of Health and Human Services (HHS) on Monday reaffirmed its support for 'mRNA research'... The HHS spokeswoman delivering that response, Emily Hilliard, previously personally provided communications services to Pfizer through Hill & Knowlton Strategies, according to her federal financial disclosure. Her Hill & Knowlton tenure ran from November 2021 through April 2023, during the COVID-19 vaccine era.

Journal of Independent Medicine Features Global Scientific Perspectives in New Issue Volume 2, No. 5 brings together U.S. and international researchers to examine emerging questions in medicine, including a new reanalysis of FDA data co-authored by Dr. Peter McCullough Washington, D.C. (Sept 22, 2026) — The Independent Medical Alliance (IMA) today announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), continuing the journal’s growing international reach and its mission to advance rigorous, conflict-free scientific inquiry through collaboration among physicians, researchers, and experts from around the world. This latest issue reflects an increasingly global scientific community examining health challenges that extend far beyond national borders. Its ten articles span metabolic health and fasting, cancer biology, COVID-19 public health policy, pharmacovigilance, vaccine regulatory science, cardiovascular pathology, dermatology, medical publishing, and freedom of scientific discourse. “Medicine has always advanced when physicians and scientists learn from one another, and today that conversation must be global,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) and President and Chief Medical Officer of IMA. “The challenges facing patients do not stop at borders, and neither should scientific inquiry. As IMA continues to expand its international relationships, the Journal gives experts from different countries, specialties, and clinical environments a place to bring their observations and research into the same conversation—grounded in evidence, transparency, and a shared commitment to patients.” One of the issue’s featured original investigations is “Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010),” by Nicolas Hulscher (@NicHulscher), Peter A. McCullough, MD (@P_McCulloughMD), and John A. Catanzaro (@Docjohnc). The authors reexamine regulatory and clinical-trial data from Moderna’s (@moderna_tx) recently approved mRNA influenza vaccine, using absolute benefit-risk measures to evaluate efficacy, adverse events, evidentiary basis and question the vaccine’s overall benefit-risk profile and argue that their findings warrant further scrutiny of its continued licensure. The breadth of the new issue also underscores an important distinction at the heart of IMA’s approach to scientific independence: independent medicine does not mean working alone. “Scientific independence should expand the conversation, not narrow it,” Varon added. “When researchers with different backgrounds and perspectives can examine evidence openly, challenge assumptions, and publish findings without commercial or political pressure, science becomes stronger. That is what Honest Medicine is about, and it is exactly the kind of international scientific community we want this Journal to continue building.” Read the full statement and find Volume 2, No. 5 and all previous issues of the Journal of Independent Medicine - links below. 🔽

The evidence has been analyzed, the extreme safety hazards have been documented, and the findings have now been peer-reviewed and published. NO excuses remain. mFLUSIVA must be removed from the market. journalofindependentmedicine…

BREAKING: Our FDA Data Reanalysis Demanding MARKET WITHDRAWAL of Moderna’s mRNA Flu Shot Is Now PEER-REVIEWED and PUBLISHED The FDA’s own data now sit in the peer-reviewed record showing a 155% higher risk of UNEXPLAINED DEATH, a 515% higher risk of DISABLING REACTIONS, and an EXTREME risk-benefit imbalance. When putting benefits and harms on the same scale, we found that it’s a form of HUMAN SACRIFICE to administer mFLUSIVA. To theoretically prevent ONE flu hospitalization: 2 people suffer unexplained deaths. 278 people suffer a disabling Grade 3 reaction. 3,798 people suffer an adverse event. Our peer-reviewed study now provides Secretary Kennedy substantial scientific firepower to fulfill the demands of his supporters and HALT mRNA technology. Regulators have NO legitimate basis to ignore these horrific data. Market removal of mFLUSIVA is now REQUIRED to protect public safety.

Our paper released this month demonstrates the dangers of allowing Spike protein to build up in the body after mRNA vaccination. The rationale for McCullough Protocol Base Spike Detoxification with exogenous enzymes is solid. In my clinical experience, Spike syndromes do not resolve without it. @McCulloughFund @NicHulscher @neo7bioscience @Docjohnc 2026 John A. Catanzaro, NMD, PhD, Peter A. McCullough, MD, MPH, Nicolas Hulscher, MPH. International Journal of Innovative Research in Medical Science

Even though COVID-19 boosters genetically code for a milder S-protein variant, the accumulation of Spike in tissues is unnatural; intensifying with each shot it likely leads to future proteostatic collapse. Courtesy Catanzaro et al 2026. @McCulloughFund @stevegrubershow @RealAmVoice @NicHulscher @Docjohnc @neo7bioscience @ijirms

Customized To Clear Cancer! Podcast Link, Listen In: johncatanzaro.substack.com/p… Dr. John Catanzaro is a pioneering leader in precision molecular medicine, specializing in personalized peptide engineering, OMICS-driven bioinformatics therapeutics, and signal-based molecular interventions. He earned his Doctorate of Naturopathic Medicine from Bastyr University in 1995 and a Doctorate of Theology in Science and Medical Ethics from Bethany Divinity Seminary in 2012. Dr. Catanzaro is a Co-founder of Neo7Bioscience, which was born of his desire to help critically ill cancer patients who have exhausted traditional treatment options and are seeking alternatives. He is a relentless advocate for next-generation patient-specific therapeutics. His work bridges the frontier of cutting-edge science and transformative clinical applications, shaping the future of precision medicine through intelligent molecular signaling and redefining personalized healthcare, while adhering to the highest legal and ethical business standards.

CDC data reveal babies are dying at rates 50% above normal since women were mass-injected with mRNA gene therapies. TRANSGENERATIONAL fatal adverse events are a serious concern as studies are now finding mRNA and spike protein inside placentas and fetal cells. It’s time for criminal charges.

Withdrawing COVID-19 mRNA vaccines is only the beginning. The broader and more urgent population-level danger is the mRNA platform itself—the engine powering an expanding pipeline of genetically engineered products. Immediate suspension, independent investigation, and the strongest black-box warning are imperative. nitter.net/docjohnc/status/209999…

(PEER-REVIEWED STUDY LINK) Recombinant SARS-CoV-2 Spike Protein and Prion-Like Domains: Persistent Cross-Seeding of Amyloid-β and Tau, Transcriptional Instability, and Tissue Dysfunction: ijirms.in/index.php/ijirms/a…

BREAKING: Our study revealing that spike protein drives PRION-LIKE protein misfolding has now been PEER-REVIEWED and PUBLISHED. BILLIONS of people were exposed to LAB-MADE spike protein containing PRION-LIKE DOMAINS capable of promoting dangerous protein clumping. This helps explain spike-associated CREUTZFELDT-JAKOB DISEASE, amyloid microclot formation, large WHITE FIBROUS CLOTS, and progressive multi-organ damage. Those responsible must be held to account. @Docjohnc @P_McCulloughMD

Withdrawing COVID-19 mRNA vaccines is only the beginning. The broader and more urgent population-level danger is the mRNA platform itself—the engine powering an expanding pipeline of genetically engineered products. Immediate suspension, independent investigation, and the strongest black-box warning are imperative.

We’ve published the first-ever HEART CANCER with a tumor doubling time of just 10 DAYS... and Pfizer COVID-shot DNA was found INSIDE the tumor. This truly is the SMOKING GUN for turbo cancers.

Cancer is not static — and precision oncology cannot afford to treat it that way. A molecular profile can provide an important snapshot, but tumors can contain different cell populations, respond differently to therapy, and change over time. That is why the future of precision oncology is moving beyond isolated findings toward molecular context. At NEO7 Bioscience, we look at the bigger biological picture — genomics, gene expression, proteins, signaling pathways, treatment history, and response over time — to better understand what may be driving disease now, not just what was present at the beginning. Because the result is information. The context is what gives it meaning. Read the full article on Substack: beyondbio.substack.com/p/bey… Beyond the Mutation: Why Precision Oncology Is Becoming More Dynamic

This is the TURBO CANCER smoking gun… We just found Pfizer spike-encoding DNA directly inside a TURBO HEART CANCER. The hyper-aggressive tumors DOUBLED in size every 10 days. He died after the turbo cancer spread into his brainstem. It’s now undeniable: mRNA “vaccine” turbo cancer is REAL.

A result can tell you something. But without context, it may not tell you what actually matters. In precision medicine, information becomes meaningful when we look beyond a single number and ask a better question: what does this mean for this individual, in this moment, within the full picture of their biology? Biomarkers, molecular signals, clinical history, environment and lifestyle can all add another layer of understanding. The goal isn’t simply to collect more data. It’s to interpret the right data in the right context. At NEO7 Bioscience, that’s where our work begins. Through precision molecular solutions, we focus on uncovering and interpreting the biological information that can help bring greater clarity to the individual—not just the average. Because precision isn’t about knowing more. It’s about understanding what matters. NEO7 Bioscience Precision Molecular Solutions.

The reviews are in, but to us, these words mean so much more than a rating. 🤍 Behind every review is a person who trusted NEO7 Bioscience with something deeply personal — their health, their questions, their hope, and their journey forward. We never take that trust lightly. It is an honor to listen, to care, to keep searching for better answers, and to walk alongside each individual with an approach built around who they are — not a one-size-fits-all standard. To every patient, provider, and person who has placed their trust in our team: thank you. Your stories are the reason this work matters so deeply. Real people. Real stories. Real experiences. Trust those who have trusted us.